Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02095353 · ClinicalTrials.gov registry record
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
A clinical trial, sponsored by University of Nebraska.
- Terminated
- Registry status
- 6
- Enrollment target
NCT02095353: Clinical Trial study, sponsored by University of Nebraska.
NCT02095353 is a clinical trial that was terminated before completion, run by University of Nebraska. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02095353 was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
This study will compare the use of two contrast agents to analyze blood flow characteristics of brain tumors.
Primary Outcome
Two contrast agents will be administered in different MRI imaging sessions. Will measure how the appearance of brain tumors change during dynamic first pass contrast administration.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-09-01 |
| Est. Completion | 2017-03-07 |
Why NCT02095353 stopped before completion
NCT02095353 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02095353 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02095353 about?
NCT02095353 is a clinical study titled "Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients". This study will compare the use of two contrast agents to analyze blood flow characteristics of brain tumors.
What is the current status of trial NCT02095353?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2014-09-01. Estimated completion is 2017-03-07.
Who is sponsoring clinical trial NCT02095353?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI